Congenital heart disease (CHD) is the most common congenital disorder in neonates.
A number of factors including genetic factors, teratogenic exposure and several other unrecognised factors have been associated with its development.
Ventricular Septal Defect (VSD) is the most common type.
Congenital Heart Defects are structural abnormalities of heart and/or great blood vessels during fetal development.
CHDs account for about 28% of all congenital anomalies. It is a result of lack of normal development of heart during the embryonic phase.
Prevalence- 1% births in the United States.
1.5-1.7/1000 live births in India.
Mostly unknown.
Sometimes associated with –
• Chromosomal abnormalities and Genetic disorders
• Teratogenic factors including maternal smoking, alcohol abuse, exposure to retinoid, indomethacin, tocolytics.
• Maternal infection with rubella.
• Additionally, history of epilepsy in mother, phenylketonuria, maternal age above 30, Type 1 and Type 2 DM as well as positive family history are other risk factors.
ASD –
• Abnormal opening in the septum between right and left atrium.
• Normally L to R shunt.
• Most common type is secundum ASD (80%).
• Wide fixed split s2 is the pathognomic for ASD.
• Clinical manifestations are non-specific.
• Defect in interventricular septum.
• Shunting of blood from L to R.
• Most common type is peri membranous.
• Holosystolic/ high pitched murmur
• Small VSDs are usually asymptomatic. Moderate VSDs can cause frequent respiratory infections and fatigue.
• Larger VSD can lead to reversal of shunt in Eisenmenger syndrome.
• 4 Defects are present in the heart
1) Right ventricular outflow obstruction
2) Right ventricular hypertrophy
3) Overriding aorta
4) Ventricular septal defect
• Clinical manifestations include cyanosis, tachypnoea, “tet spells”
• Harsh systolic ejection murmur (best heard at left sternal border)
• Boot shaped heart on CXR.
• Surgical repair definitive
• Narrowing of the descending aorta typically located at the insertion point of the ductus arteriosus, just distal to the left subclavian artery
• Often associated with bicuspid aortic valve and turners syndrome
• Posterior rib notching and figure 3 sign on CXR.
• Condition in which ductus arteriosus (small artery which connects fetal pulmonary artery to aorta) remains patent and does not close after birth.
• Epidemiology –
1. Prematurity
2. 2:1 female predominance
3. Higher altitude
4. Congenital rubella
• Caused from continual prostaglandin E1 production
• Continuous machine-like murmur and bounding peripheral pulses on physical exam.
Prevention of congenital anomalies is important as the impact can be for life. Environmental factors known to be the risk factors in etiology need to be suitably addressed. First approach should be for families with children or relatives with CHD. Second, environmental factors need to be suitably addressed.
Early detection is desirable. The suspicion of CHD is mainly clinical. Evaluation should be done on the basis of Nadas’ criteria for diagnosis of CHD.
The major criteria include -
1. Systolic murmur grade 3 or more
2. Diastolic murmur
3. Cyanosis
4. Congestive cardiac failure
The minor criteria include –
1. Abnormal echo
2. Abnormal X ray
3. Abnormal BP
Presence of 1 major or 2 minor criteria indicates heart disease.
In infants, feeding difficulties are common. Others include poor weight gain, irritability, breathing difficulty, inappropriate sweating and persistent cough.
1.
The way that miR-377 inhibits cells that cause prostate cancer.
2.
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
3.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Survivors of childhood brain cancer are more likely to be held back in school
1.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
2.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
5.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation